Janux Therapeutics, Inc. JANX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-06-11
Janux Therapeutics, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 2,344,007 | $98.2M |
| Point72 Asset Management, L.P. | 1,156,140 | $16.1M |
| CITADEL ADVISORS LLC | 444,577 | $6.2M |
| MILLENNIUM MANAGEMENT LLC | 386,810 | $5.4M |
| TWO SIGMA INVESTMENTS, LP | 116,099 | $1.6M |
| D. E. Shaw & Co., Inc. | 98,395 | $1.4M |
Source: SEC EDGAR filings · CIK 0001817713 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.